Cheyne Capital Management (UK)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-29,000	Closed	-$2.04M	–	61
2013 Q4	$2.04M	Sell	29,000 -1,000	-3%	-$70.3K	2.2%	17
2013 Q3	$2.17M	Buy	+30,000	New	+$2.17M	1.64%	14